Article
20 Jan 2023
Digital Health: Significant FDA Policy Developments In 2022
AUTHORS CONTENT
Article
20 Jan 2023
Digital Health & Telehealth – A Patchwork Of Privacy Laws Continues
Article
29 Dec 2022
FDA Expands Inspection Guidance To Apply To Device Manufacturers
Article
09 Aug 2022
FDA Delays Enforcement Of UDI Reporting Requirements For Consumer Health Products
Article
22 Jul 2022
FDA Issues Final Guidance On Drug And Biological Instructions For Use (IFU)
Article
01 Jun 2022
Digital Health In The Metaverse: Three Legal Considerations
Article
20 May 2022
FDA White Paper Signals Shift To Performance-Based Reviews Of Mature Quality Systems
Article
07 Feb 2022
Top 5 Legal Issues In Digital Health To Watch For In 2022
Article
13 Jan 2022
FDA Releases Guidances On Transition Plan For Devices Distributed Under Emergency Use Authorization (EUA) Or Enforcement Policies During COVID-19
Article
10 Jan 2022
FDA Releases Guidance For Digital Health Tech Used In Clinical Investigations
Article
26 Nov 2021
FDA Joins Other Regulators In Focus On AI And Machine Learning
Article
10 May 2021
FDA Proposes Risk-Based And Remote Inspection Strategies In New Report
Article
16 Apr 2021
Breaking Down FDA's New Remote Monitoring Strategy
Article
06 Apr 2021
New State Genetic Privacy Law Directed At Consumer Genetic Tests
Article
31 Mar 2021
FDA Announces Facility Fees For OTC Drug Manufacturers
Article
22 Feb 2021
Recent FTC Settlement Serves As Reminder For Digital Health Developers
Article
10 Feb 2021
FDA Appointment Signals Increased Attention On Medical Device Cybersecurity
Article
13 Jan 2021
FDA's Action Plan For Artificial Intelligence: Highlights And Insights For Developers
Article
05 Oct 2020
FDA's Proposed Rule On "Intended Use" Confirms Agency Will Rely On "Any Relevant Source" Of Evidence
Article
28 Sep 2020
FDA Update: The Latest On Vaccine Development, Inspections, And Conducting Clinical Trials During Covid-19